During Clinical TB Webinar, Thursday, June 24th @ 16:00 CET the panel of experts and the audience will discuss a case of tuberculosis - the history of the disease and its management. After the case discussion, there will be a lecture on MDR-TB.
Speakers
Case presenter:
Dr Animesh Sinha
Animesh is working as a HIV/TB/Hepatitis Advisor with the Manson Unit at MSF UK. He started his medical career in 2004 as a physician and emergency healthcare provider in remote areas of India with limited access to healthcare. He joined MSF in 2011 and worked in South Sudan, Uzbekistan, Chechnya, and Belarus. Animesh holds a medical degree from Armed Forces Medical College, India, and a Master’s in Infectious Diseases from the London School of Hygiene and Tropical Medicine, UK. He is also an advocate for access to new drugs and regimens for drug-resistant tuberculosis patients.
Keynote lecture:
Dr. Ilaria Motta
Ilaria is an infectious diseases physician with experience in managing HIV and TB infections in resource-limited settings. She works as Medical Monitor for TB-Practecal Clinical Trial and as Cinical Advisor for EndTB Clinical Trial. She has completed her PhD project focusing on the pharmacokinetics of TB drugs and currently undertaking MSc in Public Health. In 2015 she worked for MSF in the Central African Republic as a medical doctor.
Expert panel:
Dr. Lorenzo Guglielmetti
Lorenzo is an Infectious Diseases physician and researcher in Epidemiology at Médecins Sans Frontières (MSF) and at the National Reference Center for Mycobacteria in Paris, France. His research focuses on developing new treatment approaches for drug-resistant tuberculosis. Within the TBnet, he is responsible for Clinical Trials.
Dr. Gabriella Ferlazzo
Gabriella Ferlazzo is a Medical Doctor, specialized in Infectious Disease. She works as Senior TB/HIV adviser for MSF Southern Africa Medical Unit (SAMU), with a focus on TB/DRTB. She provides technical, strategic and operational research support to MSF projects in several countries and is co-investigator in MSF clinical trials endTB and endTB Q. Her main areas of work are DRTB treatment strategies, TB Preventive Therapy (TPT) and TB/DRTB in advanced HIV and in children.
No registration required